FDA Import Refusal AEK-7111920-7/41/1 — ASTRA ZENECA
The FDA refused shipment AEK-7111920-7/41/1 from ASTRA ZENECA (United Kingdom) on May 18, 2020. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 18, 2020
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75